National Summit on Preventing Pharmaceutical Waste

National Summit on Preventing Pharmaceutical Waste October 19, 2010 University of the Sciences Philadelphia, Pennsylvania Prepared by the Product Stewardship Institute

Who is PSI? Prepared by the Product Stewardship Institute • Non-profit founded in 2000 Membership • 46 States • 170+ Local governments • 55+ Corporate, Organizational, Academic Partners • Board of Directors: 7 states, 4 local agencies • Multi-stakeholder product stewardship network

What is Product Stewardship? “Product Stewardship" is a principle that directs all those involved in the life cycle of a product to take shared responsibility for reducing the health and environmental impacts that result from the production, use, and end-of-life management of the product.

Pharmaceuticals Initiative • National Dialogue Meeting #1 – June 2008 • National Dialogue Meeting #2 – Dec 2008 • Suggestion for a summit on waste reduction • SR Workgroup at the time: organizations, pharmaceutical companies, EPA, state gov’t • Workgroup focused on Controlled Substances Act change Prepared by the Product Stewardship Institute

“Source Reduction” Focus • Qualitative research under Dr. Becker’s study • Florida Department of Environmental Protection • Workgroup helped to develop agenda • Partnership with WHEN on developing educational modules also under EPA Region 3 project Prepared by the Product Stewardship Institute

PSI’s Role • Creating a forum & facilitating discussion • Listening for potential action items, policy ideas • Summarize what we hear at the meeting • Circulate for review • Next steps? Prepared by the Product Stewardship Institute

Participants’ Role • Ask questions • Share information/perspectives • Think outside the box • Be specific • Multiple contexts represented Prepared by the Product Stewardship Institute

Agenda: Prepared by the Product Stewardship Institute

Goal Develop public and corporate policy recommendations to reduce the quantity of pharmaceuticals that are no longer wanted or needed in homes and healthcare facilities. We seek to build on information and policy ideas from around the country and from different perspectives. Prepared by the Product Stewardship Institute

Focus of this Meeting This meeting will not address issues associated with drug disposal including mail-back or other take-back programs, incineration, etc. Preventing waste by reducing the quantity of drugs that are no longer wanted or needed in homes and healthcare facilities. Prepared by the Product Stewardship Institute

Challenge Complexity of the “ecosystem” Not “one-size-fits-all” Momentum is towards getting people their medicines as easily and cheaply as possible These are not reasons to avoid developing solutions Prepared by the Product Stewardship Institute

Thank you to our meeting sponsors: U.S. Environmental Protection Agency (Region 3) Purdue Pharma L.P. Prepared by the Product Stewardship Institute

Preventing Waste from Unused Prescriptions • Overview of the issue & stakeholder considerations • MaineCare initial prescription limitation policy • Discussion Prepared by the Product Stewardship Institute

Questions • What are the pros and cons of short-cycle dispensing? • Initial prescription limitations? • Are there specific contexts in which this approach would be easier to implement? • Voluntary? Mandated? • What would need to happen for this to be widely adopted (if that’s what we want)? Prepared by the Product Stewardship Institute

Questions • Should it apply to all medicines? • Only those with higher discontinuation rates? • Only those most likely to be abused? • To what extent does this depend on the context? • What are the options for pro-rating co-pays? • What would be the best possible scenario? • Are there any next steps on this topic? • Other information? • Other stakeholders? Prepared by the Product Stewardship Institute

Samples/Vouchers: Questions How can we minimize clinic sample waste? How can we encourage the use of vouchers in place of samples? What are the pros and cons? How/can this work in other contexts? Voluntary? Mandated? What would need to happen for this to be widely adopted (if that’s what we want)? Prepared by the Product Stewardship Institute

One more time… What are the pros and cons? Are there specific contexts in which this approach would be easier to implement? Voluntary? Mandated? What would need to happen for this to be widely adopted (if that’s what we want)? Prepared by the Product Stewardship Institute

Next steps? Additional information? Strategies? People? Forums? Prepared by the Product Stewardship Institute

National Summit on Preventing Pharmaceutical Waste